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Persistence of vesicular stomatitis virus New Jersey (VSV-NJ) was studied in experimentally infected hamsters (Mesocri-
cetus auratus). We used reverse transcription and nested polymerase chain reaction (RT-NPCR) to probe tissues of hamsters
inoculated with VSV-NJ Hazelhurst. Viral genomic RNA was detected in the brain, cerebellum, spleen, liver, kidney, and lung
2 months after infection, but only in the central nervous system at 10 and 12 months. Viral messenger RNA was detected
in the brain of one hamster at 2 months after infection. Replicative intermediate was detected in the spinal cord of one
hamster at 12 months. These results suggest that VSV-RNA persists in animals for long periods following infection, disease,
and convalescence. However, infectious virus was not recovered from tissues by conventional serial passages of tissue
extracts in Vero cells or by cocultivation. q 1996 Academic Press, Inc.
INTRODUCTION 1987). The genome is transcribed by the viral RNA-de-
pendent RNA polymerase complex into one 47-nucleo-
Vesicular stomatitis viruses New Jersey (VSV-NJ) and
tide leader RNA and at least six monocistronic, capped,
Indiana (VSV-IN) are antigenically and epidemiologically
and polyadenylated mRNAs. Second, the viral mRNAs
distinct Rhabdoviruses that cause vesicular stomatitis
are translated by the cellular translational machinery to
(Cartwright and Brown, 1972). Both are present in North,
produce the six structural proteins (N, P, C, M, G, and L)
Central, and South America (Hanson, 1981). A wide vari-
with the C protein gene included entirely within the P
ety of mammalian and avian species are experimentally
gene (Spiropoulou and Nichol, 1993). Third, viral proteins
susceptible. The most common naturally susceptible ani-
synthesize from the negative-stranded genome a full-
mals are cattle, horses, and swine (Yuill, 1981). Raccoon,
length positive-stranded RNA copy called the replicative
deer, and feral swine also become infected during epizo-
intermediate, which in turn serves as the template for
otics (Karstad et al., 1956). The disease in hooved ani-
synthesizing the minus-stranded genome. Both minus
mals is characterized by a febrile response and formation
and plus strands are encapsidated by the nucleocapsid
of vesicles on the mucous membranes of the mouth,
(N) protein in infected cells; however, only the minus
epithelium of the tongue, interdigital area of the feet,
strands are packaged into mature virions (Banerjee,
coronary bands, teats, and occasionally other areas of
1987; Banerjee and Barik, 1992). The nucleocapsid struc-
the body. The disease is usually selflimiting with recovery
ture contains two other minor proteins, the phosphopro-in about 2 weeks.
tein (P) and the large protein or polymerase (L), both ofVSV also infects humans (Bridgewater, 1983; Hanson
which are required for RNA polymerase activity (Ban-et al., 1950; Reif et al., 1987) and produces an acute,
erjee, 1987; Banerjee and Chattopadhyay, 1990). The gly-febrile, influenza-like illness with myalgia, headache, and
coprotein (G) forms the spikes on the viral envelope,malaise. Vesicular lesions may be present in the pharynx,
interacts with virus receptors present in susceptiblebuccal mucosa, or tongue (Yuill, 1981). A survey of 500
cells, and gives rise to and reacts with neutralizing anti-adult human sera from six Central American countries
bodies (Kelley et al., 1972). The matrix protein (M) assem-revealed an overall 48% prevalence of antibodies to VSV-
bles at the inner surface of the plasma membrane, linkingNJ and foci approaching 100% in some endemic areas
the G protein to the viral nucleocapsid structures during(Johnson et al., 1969).
the assembly and budding process of VSV (Wagner,The virus contains a linear 11-kb minus-sense single-
1987; Mancarella and Lenard, 1981).stranded RNA (Schubert et al., 1984; Rose and Schubert,
The mechanism by which VSV-NJ persists in nature is
not known. Gene sequences from VSV isolates obtained
1 Present address: CORPO ICA, Apartado Aero 29743, Bogota´, Co-
over the past 40 years shows that VSV-NJ can persist inlombia.
stable enzootic foci where it evolves slowly, probably in2 To whom correspondence and reprint requests should be ad-
dressed. Fax: (608) 262-7420. E-mail: gjl@ahabs.wisc.edu. isolation from the selective pressures of the mammalian
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immune system. For example, only six amino acid differ- not recovered from infected swine more than 6 days after
infection and neither viral antigens nor RNA persisted inences were found between the G gene sequence of 1952
and 1983 isolates from a stable VSV-NJ enzootic focus tissues (Redelman et al., 1989). In vitro studies suggest
that lymphocytes may harbor persistent virus. In a murinein Georgia (Nichol et al., 1989). Also, high sequence simi-
larity (98 to 100%) of the G gene region coding for the system, VSV replicated in cloned interleukin-2-dependent
natural killer (NK) cells but not in murine cytotoxic lym-neutralizing epitopes was found in eleven VSV-NJ iso-
lates obtained over a 16-month period from an enzootic phocytes (Rosenthal et al., 1986). Normal cell protein
synthesis was not altered and these cells became resis-region in Costa Rica (Vernon et al., 1990). The G gene
sequence is not tightly constrained as shown by the 38 tant to lysis by immune cytotoxic lymphocytes. Also, VSV-
IN persists in or on a murine virus-specific T cell cloneamino acid differences between 1983 isolates from Cali-
fornia and Panama (Nichol et al., 1989) and the ability of and lyses target cells by infecting them (Hom et al., 1989).
The goal of this study was to document the persistencethe G gene to mutate to evade neutralization (Luo et
al., 1988). The random distribution of the glycoprotein of virus and viral RNA in hamsters inoculated with fully
virulent VSV-NJ. The results confirm previous studiessequence differences among various VSV-NJ isolates
(Nichol et al., 1989) might suggest that the evolutionary (Fultz and Holland, 1985) showing that virulent VSV-NJ
does not persist in an infectious state in convalescentpressure by immune selection of variant viruses clearly
seen in vitro (Bricker et al., 1987; Holland et al., 1979; hamsters and extends these results to show that viral
genomic, messenger, and replicative intermediate RNAsLefrancois and Lyles, 1983a; Lefrancois and Lyles,
1983b; Luo et al., 1988; Rowlands et al., 1980; Vandepol detectable by polymerase chain reaction (PCR) persist
as long as 12 months.et al., 1986; Vandepol and Holland, 1986) is a minor factor
in nature. The observed evolutionary pattern is more con-
sistent with evolution driven by defective interfering parti- MATERIALS AND METHODS
cles (DePolo et al., 1987; Horodyski and Holland, 1984),
Cells and virusesthe founder effect (Strickberger, 1990), or the spread into
and adaptation to a successive series of different ecolog- African Green Monkey (Vero) cells were grown in mini-
ical niches (Nichol et al., 1993); however, it does not mal essential medium (MEM) (Gibco Laboratories, Grand
suggest whether this process is occurring in vertebrate Island, NY) supplemented with 5% fetal bovine serum
hosts or insect vectors. (Hyclone Laboratories, Logan, UT). The prototype strain,
The evidence for VSV persistence in an insect reser- VSV-NJ Hazelhurst was obtained from Dr. R. P. Hanson
voir is well documented for VSV-IN. VSV-IN has been at the Department of Animal Health and Biomedical Sci-
isolated from Phlebotomine flies (Shelokov and Peralta, ences, University of Wisconsin at Madison. This virus
1967; Tesh et al., 1987) in which the virus replicates had been passaged more than 20 times in 9- to 10-day-
efficiently (Johnson et al., 1969) and is transmitted trans- old chicken embryos but was highly virulent by intrader-
ovarially (Tesh et al., 1972). Insect transmission of VSV- mal inoculation in cattle. A master stock was prepared
NJ has also been suggested by Stallknecht et al. (1987) after two serial passages in confluent Vero cell mono-
based on seroconversion of sentinel pigs kept in ele- layers infected at a multiplicity of infection (m.o.i.) of ap-
vated isolation pens in the VSV-NJ enzootic area of Ossa- proximately 0.05. The virus suspension was clarified from
baw Island, Georgia, by experimental studies on replica- cell debris by centrifugation at 800 g for 10 min at 47 and
tion and transmission of VSV-NJ in Lutzomyia shannoni aliquots of this stock were kept at 0807. The virus stock
(Comer et al., 1990) and by the isolation of VSV-NJ from was titrated by a standard plaque assay and by the lim-
wild L. shannoni captured on Ossabaw Island (Corn et iting dilution method in 96-well microtiter plates (Linbro,
al., 1990). New Haven, CT).
Several observations suggest that VSV may persist in
convalescent animals. Hughes et al. (1985) recovered PCR primers
virus from mice 90 days after infection with temperature
sensitive VSV-NJ by injecting the neuropeptide bombesin Oligonucleotide primers were based on published se-
quences for the L (Feldhaus and Lesnaw, 1988), G (Ni-to induce a hypothermia of about 87. Persistent infection
by VSV-IN was established in Syrian hamsters inoculated chol et al., 1989), and N (Bilsel et al., 1990) genes of the
VSV-NJ Hazelhurst strain. The polymerase (L) gene wasintraperitoneally with a mixture of standard virus and
defective interfering (DI) particles (Fultz et al., 1982). In- selected because it is essential for viral replication and
is rarely absent from defective interfering particles. Thefectious virus was isolated from brain, spleen, and liver
until 8 months after infection. In contrast, when the same G gene was selected to enable amplification across the
G-L gene boundary in the replicative intermediate. Theexperiment was repeated with the VSV-NJ serotype, little
or no virus was present in tissues past 3 days after N gene region was selected because the subgenomic
mRNA from this region is the most abundant during RNAinfection (Fultz and Holland, 1985). Similarly, VSV-NJ was
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ate or mRNA. Regions with high G-C content were used
to provide the high melting temperatures needed for PCR.
All the primers had a predicted melting temperature of
667 based on calculation of 27 for A or T and 47 for G or
C (Wallace and Miyada, 1987). Primers were synthesized
at the Biotechnology Center, University of Wisconsin at
Madison.
Reverse transcription (RT)-PCR
Single-stranded cDNA was produced from purified
RNA by primer extension/reverse transcriptase reaction
(Sambrook et al., 1989). Sample RNA (4 mg) was dis-
solved in 6.5 ml of DEPC-treated H2O. The RNA was dena-
tured with 2.0 ml of 0.1 M methylmercuric hydroxide
(MeHgOH) (Alfa Products, Danvers, MA) at room temper-
FIG. 1. Methods to amplify selectively the VSV-NJ genomic, replica-
ature for 5 min. The MeHgOH was neutralized on ice fortive intermediate, and N gene messenger RNAs. In each case, a single
10 min with 2.5 ml of 0.7 M 2-mercaptoethanol (Sigma,primer indicated by a heavy arrow was used in reverse transcription
to make a cDNA copy, the reverse transcriptase was heat inactivated, St. Louis, MO). The negative or positive sense primer
and the cDNA was amplified by nested PCR. Specifically, genomic was added (1 ml of 13.8 mM) and incubated at 657 for 5
L gene RNA was detected by reverse transcription with the L5687P min. The primers N584P and L5687P were used to detect
(GTGGGAATCCCTCCCCAATTC) primer followed by heating to destroy
VSV-NJ genomic RNA, the primer L161N to detect replica-the reverse transcriptase and amplification with the external primers
tive intermediate RNA, and the primer N1139N to detectL5687P and L6139N (CAACTCCCAAGCTCTAATCCAG) to produce a
474-bp product that was itself detected by amplification with the nested N-mRNA (Fig. 1). The RT reaction was initiated by adding
primers L5740P (GTTTCAAATAGCGGGGGTCCC) and L6095N (CTC- 13 ml of a premix composed of 5 ml of 51 M-MLV RT
CCAATCTGGAATCCTTAGG) to produce a 377-bp product. Genomic N buffer (250 mM Tris–HCl, pH 8.3; 375 mM KCl; 15 mM
gene RNA was detected by reverse transcription with the primer N584P
MgCl2), 5 ml of 10 mM dATP, dCTP, dGTP, and dTTP(TTCACCAAGATAGTGGCTGCAG) followed by heating to destroy the
(dNTPs) (Boehringer Mannheim Biochemicals, Indianap-reverse transcriptase and amplification with the external primers N584P
and N1139N (ATACCAGCCAAGCCAGTCCAC) to produce a 576-bp olis, IN), 1.35 ml of 0.1 M dithiothreitol (DTT), 0.65 ml of
product that was itself detected by amplification with the nested prim- rRNasin (26 units, Promega, Madison, WI), and 1 ml (200
ers N654P (GATACGGAACCATAGTCTCACG) and N1030N (CTGTTC- units) M-MLV reverse transcriptase. The DTT, M-MLV
AATGTCTGCTGAGGAC) to produce a 398-bp product. Messenger RNA
RT buffer, and M-MLV reverse transcriptase were fromfrom the N gene was detected by enrichment of mRNA with the PolyA-
GIBCO BRL, Life Technologies, Inc. (Grand Island, NY).tract mRNA isolation System (Promega), reverse transcription with the
N1139N primer, heating to destroy the reverse transcriptase, and ampli- The cDNA synthesis was carried out at 377 for 1 hr and
fication with the same N584P/N1139N external and N654P/N1030N the reverse transcriptase was inactivated by boiling for
nested primer pairs used for genomic N gene RNA. The replicative 5 min. The entire 25 ml of the cDNA reaction mixture was
intermediate RNA was detected by reverse transcription with the L161N
amplified by adding 54 ml of H2O, 1 ml of 13.8 mM forward(ATGTCATCTGATATGAGCGGAGA) primer followed by heating to de-
and reverse primer, and 9 ml of 101 Taq DNA polymerasestroy the reverse transcriptase and amplification with the external prim-
ers L161N and G1168P (GGCTGAGATTGGACCCAATGG) to produce a buffer (500 mM KCl, 100 mM Tris–HCl, pH 9.0, at 257, 15
596-bp product that was itself detected by amplification with the nested mM MgCl2 , 1.0% Triton X-100, 0.1% Gelatin (w/v); Pro-
primers G1240P (AGGAGAGGTAGACAGTGACATC) and L52N (CTC- mega, Madison, WI). To preclude aberrant annealing, the
CCAGTGAGTAGAATCTTCG) to produce a 414-bp product.
samples were heated at 937 for 3 min in a thermal cycler
(Coy Corporation, Grass Lake, MI) before adding 10 ml
of a premix composed of 0.8 ml H2O, 1 ml of Taq DNAtranscription (Banerjee, 1987) and because this region
is frequently absent in VSV DI particles (Holland, 1987). polymerase 101 buffer, 8 ml of 10 mM dNTPs, and 0.2
ml (1 unit) of Taq DNA polymerase (Promega, Madison,Primer names were composed from the gene (L, G, or
N), the number of the 5* end on the gene sequence as WI) to make a final 100 ml volume (Mullis, 1991). The
cDNA was amplified for 35 cycles (937 for 120 sec, 607published (Feldhaus and Lesnaw, 1988; Nichol et al.,
1989; Bilsel et al., 1990), and the sense, either positive for 90 sec, and 727 for 105 sec). After the last cycle, the
samples were incubated at 727 for 5 min then at 377 for(P) or negative (N). The location and sequence of primers
and the expected length of the PCR products are indi- 5 min for final extension, and then cooled to 47. Twenty
microliters from the first amplification step were used ascated in Fig. 1. The selectivity of the VSV RNA sequence
to be amplified depended on the sense of the primer a template for the nested amplification which was done
under the same conditions indicated above. The nestedused during the reverse transcription reaction, positive
for genomic RNA, and negative for replicative intermedi- primers used to amplify VSV genomic RNA were L5740P
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and L6095N, whereas the primers G1240P and L52N was extracted with phenol-chloroform, precipitated in
ethanol, and transcribed for 2 hr at 377 in 20 ml of 51were used to amplify the replicative intermediate RNA.
The nested primers N654P and N1030N were used to transcription buffer (200 mM Tris–HCl, pH 7.5, 30 mM
MgCl2 , 10 mM spermidine, 50 mM NaCl), 10 ml of 100identify N mRNA and the N-gene region of the VSV-NJ
genomic RNA (Fig. 1). Seven microliters of each reaction mM DTT, 100 U of RNasin, 20 ml of ribonucleotide premix
(5 ml of 2.5 mM each rATP, rCTP, rUTP, and rGTP), 30 Uwere size fractionated on a 1.5% SeaKem agarose gel
(FMC BioProducts, Rockland, ME) and visualized by of T7 RNA polymerase and 49.5 ml of H2O. Then the
DNA template was digested with 3 U of RQ1 RNase-freeethidium bromide staining and UV illumination. Negative
control amplifications were run in parallel reactions con- DNAse at 377 for 15 min. All reagents were purchased
from Promega (Madison, WI). The RNA was phenol-chlo-taining no RNA and also PCR reagents alone. Positive
controls were avoided to prevent contamination of test roform extracted and ethanol precipitated in the pres-
ence of 2 M ammonium acetate. The final RNA pelletsamples with DNA that would cause false positives par-
ticularly when doing the nested PCR. was resuspended in 50 ml of DEPC-treated H2O and
quantitated by spectrophotometry. Two micrograms ofSeveral precautions were taken to prevent VSV DNA
contamination of the PCR reactions. The RNA extractions each synthetic RNA was size fractionated in a 1.2% aga-
rose/formaldehyde gel and their integrity was evaluatedand PCR reactions were assembled in a separate, dedi-
cated laboratory. The thermal cycler was located inside a by visualization of a well defined single band after ethid-
ium bromide staining of the gel. Uninfected Vero or HeLalaminar flow chamber (The Baker Company, Inc. Sanford,
ME) where it was irradiated with ultraviolet light to de- cell RNA was purified by the guanidine isothiocyanate/
cesium chloride procedure described by Chirgwin et al.stroy possible contaminant DNA between uses. The PCR
products were analyzed in a separate room also bathed (1979). Viral RNA was isolated from virions purified by
sucrose gradient ultracentrifugation and quantitated byin UV light when unoccupied. Additional measures in-
cluded the use of dedicated pipettes, frequent change spectrophotometry. Fivefold serial dilutions of either VSV-
NJ genomic or synthetic RNAs in 4 mg (6.5 ml) of totalof gloves, lab coat, and limited movement of personnel
between rooms. cellular RNA were tested by PCR as described above
and samples of both the external and nested PCR were
Validation of PCR products analyzed on 1.5% agarose gels.
The identity of the 596- and 474-bp products amplified
Infection of hamstersfrom replicative intermediate and L gene genomic RNA’s,
respectively, was confirmed by restriction endonuclease Female Syrian golden hamsters (Mesocricetus aura-
digestion with the enzyme HaeIII, which was predicted tus) (6 weeks old) were purchased from Harlan Sprague
to cut each product once. Dawley, Inc. (Indianapolis, IN). They were caged in
The identity of the 474-bp DNA fragment amplified from groups of three, kept in isolation for 2 weeks, and inocu-
genomic RNA was also shown by hybridization to radiola- lated intraperitoneally with 10-fold dilutions of VSV-NJ
beled VSV-NJ RNA in unblots (Ahmad et al., 1990; Wallace virus ranging from 100.4 to 109.4 PFU. Three controls were
and Miyada, 1987). inoculated with one ml of PBS alone. The hamsters were
placed in cages covered by micro-isolator units (Lab
Cloning of PCR products Products, Inc., Maywood, New Jersey) to prevent cross-
contamination with virus. Animals were checked daily forThe 474-bp DNA fragment amplified from L gene geno-
onset of clinical signs and survival. At 2, 10, and 12mic RNA and 596-bp fragment amplified from L and G
months after infection, one hamster from each group wasgene replicative intermediate RNA were ligated into plas-
killed by exsanguination under CO2 anesthesia. Brain,mid pCR1000 (Invitrogen Corporation, San Diego, CA) by
cerebellum, spleen, kidney, lung, and liver samples werestandard procedures (Sambrook et al., 1989). The ends
collected aseptically. Samples were subdivided, one partof the 596-bp fragment were sequenced using the Seque-
being used for immediate virus isolation attempts andnace sequencing kit (United States Biochemical, Cleve-
another part being frozen in liquid nitrogen and storedland, OH) according to the manufacture’s directions ex-
at 0707 for later PCR analysis. Serum samples werecept that 100 ng of the forward and reverse primers
taken for evaluation of neutralizing antibody levels.(L161N and G1168P) were used.
Neutralization assaySensitivity of the PCR
To obtain synthetic RNA to perform reverse transcrip- Neutralization titers against VSV-NJ were determined
by the constant virus, varying serum microtiter virus neu-tion-PCR sensitivity assays, 3 mg of recombinant plas-
mids containing the 474- or 596-bp VSV inserts were tralization assay at the time of sacrifice. Complement
was inactivated at 567 for 30 min before the assay.linearized with the restriction enzyme EcoRI. The DNA
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Virus isolation from hamsters (Gerard and Miller, 1986), to demonstrate the presence
of intact ribosomal RNAs by ethidium bromide staining
To attempt to isolate infectious virus 2, 10, and 12 and visualization in UV light. Typically 30 to 120 mg of
months after infection, approximately 100 mg of each total RNA was recovered from each tissue sample.
tissue was homogenized at 47 in 4 ml of MEM containing Enrichment of mRNA was done with the PolyAtract
2% FBS, 100 units/ml penicillin, and 100 mg/ml streptomy- mRNA isolation System (Promega, Madison, WI) ac-
cin. After clarification at 10,000 g for 10 min at 47, 1 cording to the manufacturer’s instructions for small-scale
ml of the supernatant was used to inoculate Vero cell mRNA isolation. Since the concentration of total RNA (8
monolayers in 25-cm2 plastic flasks (Falcon, Becton-Dick- to 36 mg) used to purify mRNA was low, the quality of
inson, Oxnard, CA). Monolayers were overlayed with 4 the isolated mRNA was not evaluated.
ml MEM containing 2% FBS and incubated at 377 under
5% CO2 atmosphere. Observations for the presence of RESULTS
cytopathic effect (CPE) were done daily for 3 days and
Validation and cloning of PCR productsa minimum of three serial passages were done with each
sample. The enzymatic amplification of VSV-NJ RNAs from in-
To isolate infectious virus after 10 and 12 months post- fected Vero cells resulted in the synthesis of PCR prod-
infection, part of each tissue sample was cut into 1- to ucts of the expected sizes. No amplification occurred in
5-mm pieces, rinsed in 5 ml of MEM supplemented with reactions lacking RNA template or with RNA from unin-
2% FBS, 100 units/ml penicillin, 100 mg/ml streptomycin, fected cells or in the absence of reverse transcriptase.
and 17.4 mg/ml amphotericin B. The explants were The 474- and 596-bp PCR products were digested with
placed in 25-cm2 plastic flasks containing 5 ml of MEM HaeIII to yield the expected 354- and 120-bp, and 357-
and 6% FBS. The culture medium was changed twice a and 239-bp fragments, respectively (data not shown),
week and cell growth and presence of CPE were ob- strongly suggesting they were indeed amplified from
served daily for approximately 2 months. VSV-NJ Hazelhurst DNA sequences. The 474- and 596-
bp PCR products were cloned and verified by restriction
Hamster RNA extraction digestions. A radiolabeled DNA probe prepared from the
474-bp fragment hybridized only to VSV-NJ RNA se-Total cellular RNA was isolated by the method of Cho-
quences in an unblot (data not shown). One hundred-mezynski and Sacchi (Chomczynski and Sacchi, 1987)
sixty basepairs from both ends of the cloned 596-bp DNAmodified by the use of the RNaid Kit (BIO 101, Inc., La
fragment were sequenced to reveal the 3* end sequenceJolla, CA). Briefly, in a sterile 1.5-ml microcentrifuge tube,
of the G gene region (Nichol et al., 1989) and the 5* endapproximately 100–150 mg of frozen tissue was minced
sequence of the L gene region (Feldhaus and Lesnaw,in 500 ml of cold denaturing solution (4 M guanidinium
1988), including seven adenines in the intergenic regionthiocyanate, 25 mM sodium citrate, pH 7, 0.1 M 2-mercap-
(data not shown).toethanol, 0.5% sarkosyl) before adding 750 ml of a premix
consisting of 50 ml of 2 M sodium acetate, pH 4, 500 ml PCR sensitivity assays
phenol acid (equilibrated in sodium acetate, pH 4), and
Genomic RNA prepared from virions could be detected150 ml chloroform:isoamyl alcohol (49:1). The samples
down to 15 ag (2 copies) per sample using the L5687P/were mixed, placed at 0207 for 20 min, and centrifuged
L6139N and L5740P/L6095N primer sets as shown byat 13,000 rpm for 20 min at 47. Approximately 450 to 500
PCR products of the expected size (Fig. 2). When onlyml of the aqueous phase was transferred into a sterile
the L5687P/L6139N primer set was used, 3.6 pg (500,0001.5-ml microcentrifuge tube containing 500 ml of RNA
copies) of virion genomic RNA was detected. Syntheticbinding salt and 7 ml of RNA matrix. The sample was
genomic L gene and replicative intermediate L and Gmixed, placed at room temperature for at least 5 min,
gene RNAs were detected down to 8.5 ag (24 copies)and centrifuged at 13,000 rpm for 1 min. The supernatant
and 4.1 ag (9 copies), respectively, by the nested PCRwas removed and the RNA bound to the RNA matrix
(data not shown). In each case, 4 mg of cellular RNA waspellet was washed three times with 500 ml of washing
present in the reactions. Amplification occurred only ifsolution. The pellet was dried, resuspended in 100 ml of
reverse transcriptase was included in the reaction con-H2O previously treated with 0.2% diethylpyrocarbonate
firming that plasmid DNA had been fully digested and(DEPC) (Sigma, St. Louis, MO), and incubated at 567 for
only RNA was being amplified. The sensitivity of the N10 min to elute the RNA. The RNA concentration was
gene primer sets was not tested.estimated by absorbance readings at 260 nm, and the
quality was evaluated by electrophoresis of 1.5 mg of
Survival of hamsterstotal RNA under denaturing conditions in 1.2% agarose
(FMC BioProducts, Rockland, ME)/formaldehyde (Sigma, From the 30 infected hamsters, one hamster infected
with 105.4 PFU died 6 days after infection. One hamsterSt. Louis, MO) gels as described by Gerard and Miller
AID VY 7929 / 6a17$$$$42 04-22-96 18:02:41 viras AP: Virology
458 BARRERA AND LETCHWORTH
L5740P/L6095N primer sets. A 377-bp product indicated
that VSV-NJ RNA sequences were present in the brain,
cerebellum, spleen, liver, kidney, and lung 2 months after
infection, in the brain and cerebellum after 10 months,
and in the brain and spinal cord after 12 months (Table
1). An example of representative data is given in Fig. 3.
To test for the presence of genes more likely to be
found in complete genomes, the N gene was selected.
The N gene genomic RNA was detected in the brain and
spleen samples from hamster 1 sampled 2 months after
infection (Table 1, Fig. 3) but not in hamster 9 sampled
12 months after infection or in an uninfected control.
To confirm that these PCR products were the result of
amplification of VSV-NJ RNA and not false positives that
might have resulted from contaminant PCR products be-
ing reamplified, all positive RNAs were retested both with
and without the reverse transcriptase step. PCR products
of 377 bp were obtained in 10 of the 15 previously posi-
tive samples (Table 1), but only in reactions that includedFIG. 2. Sensitivity of RT-NPCR for detection of viral genomic RNA.
reverse transcriptase.Fivefold serially diluted VSV-NJ viral RNA was reverse transcribed with
the L5687 primer and amplified with the L5687P/L6139N and L5740P/
L6095N primer pairs. Seven microliters of each reaction were size Detection of VSV replicative intermediate and
fractionated on a 1.5% agarose gel and visualized by ethidium bromide messenger RNA in convalescent hamsters by
staining and UV illumination. The position of the expected 377-bp prod-
RT-NPCRuct is indicated. Size markers (M) are PM2 DNA digested with the
HaeIII enzyme. To attempt to clarify the mechanism of VSV-NJ RNA
persistence, all RNA samples from which genomic RNA
infected with 106.4 PFU was euthanized because of se- was amplified were retested for VSV-NJ replicative inter-
vere illness 13 days after infection. The remaining in- mediate RNA. The negative sense primer L161N was
fected hamsters survived the acute infection. One ham- used to synthesize cDNA during reverse transcription,
ster (hamster 9 infected with 107.4 PFU) developed perma- and the nested primer sets L161N/G1168P and L52N/
nent hind limb paralysis starting at Day 5 after infection. G1240P were used in the first and second PCR reactions,
Hamsters 3, 29, and 33 (infected with 109.4, 100.4, and respectively. A PCR product of 414 bp (Fig. 4) derived
mock infected, respectively) died of kidney failure 10 from the replicative intermediate RNA form was detected
months after infection but the exact etiology was not only in the spinal cord of the paraplegic hamster 9. The
established. The possibility of lymphocytic choriomenin- absence of contaminating replicative intermediate DNA
gitis virus (LCMV) activity was eliminated by serology. was shown by repeating the amplification in the pres-
ence but not in the absence of reverse transcriptase.
Absence of infectious virus
Brain and spleen samples from hamster 1 and brain
Infectious virus was not identified in Vero cells inocu- samples from hamsters 9 and 32 were tested for N gene
lated with tissue extracts collected at 2, 10, or 12 months mRNA. This was only identified in the brain sample of ham-
after infection or from tissue explants at 10 and 12 ster 1 sampled 2 months after infection (Table 1, Fig. 5).
months after infection.
DISCUSSIONConfirmation of VSV infection by neutralization assay
The goal of this research was to identify persistentMost inoculated animals developed neutralizing anti-
VSV-NJ in convalescent animals. Our approach was tobodies (Table 1). The fact that neutralizing antibody titers
search for both replication-competent virus by conven-had a bimodal distribution with all samples either103.25
tional methods and all forms of viral RNA by an exqui-or 101.45 strongly suggests that animals either were
sitely sensitive RT-NPCR. We were unable to find replica-infected and developed a neutralizing response or they
tion-competent virus. However, we developed an RT-did not become infected.
NPCR protocol that detected viral RNA in many convales-
Detection of VSV genomic RNA in convalescent cent animals. The strategy of using appropriate primers
hamsters by RT-NPCR in the reverse transcription reaction permitted the selec-
tive amplification of genomic or replicative intermediateAll tissue samples from each hamster were tested for
VSV genomic RNA using the nested L5687P/L6139N and RNA. A similar strategy was used previously to distin-
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TABLE 1
Detection of VSV-NJ L and N Gene Genomic RNAs, the L-G Gene Junction of the Replicative Intermediate, and N Messenger RNAs in
Tissues of Convalescent Hamsters Previously Infected with VSV-NJ Hazelhurst
Hamster VSV-NJ Months after Genomic L Genomic N RI-L/G N mRNA
number inoculum infection Seroconversiona PCRb PCR PCR PCR
1 109.4 2 / /Br, Sp, Li, (Lu) /Br, Sp Neg. /Br, not Sp
6 108.4 2 / /Sp, (Ki) NT Neg. NT
7 107.4 2 / /Sp NT Neg. NT
12 106.4 2 / /Sp NT Neg. NT
14 105.4 2 / /Sp, (Ce) NT Neg. NT
16 104.4 2 / /Sp NT Neg. NT
20 103.4 2 / Neg. NT NT NT
24 102.4 2 / /(Lu) NT Neg. NT
25 101.4 2 Neg. Neg. NT NT NT
28 100.4 2 Neg. /(Li) NT Neg. NT
32 0 2 Neg. Neg. Neg. Neg. Neg.
2 109.4 10 / /Br NT Neg. NT
4 108.4 10 / Neg. NT NT NT
8 107.4 10 / /Ce NT Neg. NT
10 106.4 10 / Neg. NT NT NT
15 105.4 10 / Neg. NT NT NT
18 104.4 10 / Neg. NT NT NT
31 0 10 Neg. Neg. NT NT NT
5 108.4 12 / Neg. NT NT NT
9 107.4 12 / /Br, Sc Br Neg., Sc NT /Sc Br Neg., Sc NT
17 104.4 12 / Neg. NT NT NT
19 103.4 12 / Neg. NT NT NT
22 102.4 12 Neg. Neg. NT NT NT
23 102.4 12 Neg. Neg. NT NT NT
26 101.4 12 Neg. Neg. NT NT NT
27 101.4 12 / Neg. NT NT NT
26 100.4 12 Neg. Neg. NT NT NT
S 0 12 Neg. Neg. NT NT NT
a Sero-conversion: ‘‘/’’ indicates neutralizing titers 103.25; ‘‘Neg.’’ indicates neutralizing titers 101.45.
b Genomic L PCR: Br, brain; Ce, cerebellum; Ki, kidney; Li, liver; Lu, lung; Sc, spinal cord; Sp, spleen from each hamster were tested. ‘‘/’’ indicates
positive amplification from the listed tissue. Tissue in parenthesis indicates the positive result was not repeated in a confirmatory test. ‘‘Neg.’’
indicates no amplification from any tissue. NT, not tested.
guish between sense and antisense RNA in rabies infec- eral months after infection. In contrast, VSV-IN has been
isolated from brain, spleen, and liver as long as 8 monthstion (Shankar et al., 1991). Optimization of the reverse
transcription and PCR conditions allowed us to detect after infection from hamsters coinoculated with standard
virus and DI particles. The differences are not surprising;as little as 15 ag of VSV-NJ genomic RNA, the amount of
RNA present in two virions. This represents a 10 million- the establishment and maintenance of persistent infec-
tions by VSV appears to depend on the system used,fold improvement over the hybridization assays pre-
viously used to detect VSV RNA sequences in mice (Cave temperature-sensitive mutants (Doll and Johnson, 1988),
DI particles (Cave et al., 1985), or interferon (Sekellicket al., 1984). The disadvantage of the RT-NPCR protocol
is that it cannot distinguish between full-length RNAs and Marcus, 1989). In our system, the virus used was
VSV-NJ Hazelhurst propagated in Vero cells. This virusand small RNA fragments.
In the past, viral clearance following VSV infection has was considered a laboratory strain that was not thermo-
sensitive, was propagated at low multiplicity to selectbeen inferred from the inability to isolate infectious virus
or demonstrate viral antigens or RNA in convalescent against DI particles, and was fully virulent when injected
into cattle (data not shown).animals (Redelman et al., 1989; Forger et al., 1991). In
our experiments, infectious virus was only isolated from Based on the PCR results, 8 of the 10 inoculated ham-
sters tested at 2 months after infection had VSV-NJ RNAthe brain of the hamster 13 that died 6 days after infec-
tion. Our observations of hamster survival and viral clear- sequences in the brain, cerebellum, liver, kidney, spleen,
or lung (Table 1). The requirement for nested rather thanance agree with those of Fultz et al. (Fultz and Holland,
1985) who found VSV-IN but not VSV-NJ in hamsters sev- single RT-PCR for detection of VSV-NJ RNA sequences
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1986; Ahmed and Stevens, 1990) perhaps because neu-
ronal cells do not express sufficient class I major histo-
compatibility complex (MHC) protein to complex with vi-
ral peptides and serve as targets for killing by cytotoxic
T lymphocytes (Joly et al., 1991). We did not test for the
presence of specific VSV-NJ antigens in tissues but spec-
ulate that the viral RNA might have been encapsidated
in nucleocapsid (N) protein (Banerjee, 1987).
Viral RNA was detected more frequently from ham-
sters inoculated with higher doses of virus. The mean-
ing of this is not clear since it is probable that the virus
replicated to similar levels regardless of the original
inoculum.
We used the presence of neutralizing antibodies to
confirm that hamsters were successfully infected. By this
criterion, only some hamsters given 100.4 to 102.4 PFU
were infected. Amplification of VSV-NJ sequences from
the liver of hamster 28, which never developed neutraliz-
FIG. 3. The VSV-NJ N and L gene genomic RNA’s were detected in ing antibodies and therefore probably was not success-
tissues of convalescent hamster 1 at 2 months and hamster 9 at 12 fully infected, appears anomalous. Since this result could
months after infection but not in uninfected hamster 32. The N584P or not be repeated, we suspect it was a false positive per-
L5687P primers were used during the reverse transcription (R.T.) to
haps caused by cross-contamination. We can rule outsynthesize cDNAs from the N gene and L gene genomic RNA’s, respec-
pervasive contamination by the fact that 151 of 168 sam-tively. The N584P/N1139N and N654P/N1030N primer pairs were used
to amplify the N gene and the L5687P/L6139N and L5740P/L6095N ples were negative and all mock-infected and negative
primer pairs were used to amplify the L gene. Seven microliters of each control samples were always negative.
reaction were size fractionated on a 1.5% agarose gel and visualized by The presence of high titers of neutralizing antibodies
ethidium bromide staining and UV illumination. The locations of the
at the time of sacrifice in most of the hamsters agreesexpected 398- and 377-bp products from the N and L genes, respec-
with the findings by Fultz et al. (Fultz and Holland, 1985).tively, are indicated. Size markers (M) are PM2 DNA digested with the
HaeIII enzyme. The presence of antibodies does not preclude viral per-
showed that the number of copies was below approxi-
mately 500,000. To show that these positives were not
caused by contamination with previously amplified DNA
or integration of VSV sequences into the cellular DNA by
endogenous retroviral reverse transcriptase, we re-
peated the amplifications in the presence and absence
of reverse transcriptase. Although none amplified in the
absence of reverse transcriptase, some previously posi-
tive samples were not amplified (Table 1). This might
be due to reduced sensitivity in the second test, RNA
degradation by repeated freezing and thawing, or the
presence of too few VSV RNA molecules to assure that
every 4-mg sample of total RNA contained a viral RNA
molecule.
VSV-NJ RNA sequences were found most frequently
in the spleen 2 months after infection (6 of 8 infected
FIG. 4. The VSV-NJ replicative intermediate RNA was detected in
hamsters). This organ, as well as lung and liver, is in- duplicate samples of spinal cord but not in duplicate samples of brain
volved in reoviral clearance (Verdin et al., 1987) and per- RNA of convalescent hamster 9 12 months after infection. The L161N
haps VSV clearance. We found VSV RNA only in the primer was used during the reverse transcription (R.T.) reaction and
the G1168P/L161N and G1240P/L52N primer pairs were used for ampli-central nervous system at 10 and 12 months after infec-
fication. Seven microliters of each reaction were size fractionated ontion, suggesting that this is a preferential site for VSV-NJ
a 1.5% agarose gel and visualized by ethidium bromide staining and
persistence. Our data does not suggest which CNS cells UV illumination. The location of the expected 414-bp DNA product is
were involved. It is known that neurons can be persis- indicated. Size markers (M) are PM2 DNA digested with the HaeIII
enzyme.tently infected by many viruses (Kristensson and Norrby,
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DI particles or fragments of biologically inactive RNA.
The absence of N gene RNA argues against DI particle
replication. Unfortunately, since spinal cord samples
were not collected from any other hamsters due to the
absence of hind limb paralysis we do not know if the
spinal cord of other animals contained similar viral
RNA’s. In hamster 1, infected for 2 months before testing,
genomic RNA and N-mRNA were detected in the brain,
but only genomic RNA was detected in the spleen (Table
1). Amplification of N gene mRNA can be questioned
because the replicative intermediate should be amplified
by the same primers and we could not evaluate the effec-
tiveness of our mRNA purification. However, we were
unable to amplify replicative intermediate RNA from the
unpurified sample using another set of primers, sug-
gesting that only mRNA and virtually no replicative inter-
mediate RNA was present after mRNA purification. It is
possible that RNA replication was blocked at the level
of positive-strand RNA synthesis, suggesting a static viralFIG. 5. The VSV-NJ N gene messenger RNA was found in the brain
but not the spleen samples from hamster 1 2 months after infection. It persistence as might be seen in infections with tempera-
was not found in the brain sample from hamster 9 12 months after ture-sensitive viruses. The same phenomenon has been
infection. The N1139N primer was used during the reverse transcription observed in mice persistently infected with Theiler’s virus
(R.T.) reaction and the N584P/N1139N and N654P/N1030N primer pairs
where amounts of plus- and minus-strand RNAs in in-were used for amplification. Seven microliters of each reaction were
fected central nervous system cells showed that RNAsize fractionated on a 1.5% agarose gel and visualized by ethidium
bromide staining and UV illumination. The location of the expected replication was blocked at the level of minus-stranded
398-bp DNA product is indicated. Size markers (M) are PM2 DNA RNA synthesis (Cash et al., 1988).
digested with the HaeIII enzyme. Other RNA viruses persist in the central nervous sys-
tem. Measles virus occasionally persists in human brains
causing subacute sclerosing panencephalitis. A varietysistence. High titers of circulating antibodies have been
detected in other persistent infections by paramyxovirus of F and M gene mutations precluding viral assembly
appear to be responsible (Cattaneo et al., 1988; Schmid(Fujinami and Oldstone, 1984) in which antibodies cause
antigenic modulation by the binding to viral proteins on et al., 1992). The arenavirus LCMV persists in rodent
brains. A variety of immunological and virological mecha-the infected cell surfaces resulting in repression of viral
gene transcription. Foot-and mouth disease virus per- nisms have been proposed (Oldstone, 1991). The picor-
navirus Theiler’s murine encephalitis virus persists insists in the bovine esophageal-pharyngeal region in the
presence of neutralizing antibodies (Sutmoller and Gag- murine nervous tissues (Cash et al., 1988) but persis-
tence of poliovirus in human nervous tissues has notgero, 1965) that select a succession of antigenic variants
(Gebauer et al., 1988). Virus was isolated in each of these been detected (Melchers et al., 1992). The JHM coronavi-
rus RNA persists in mouse brains for at least 360 dayssystems, in contrast with our results. However, concur-
rent clearance of infectious virus and RNA has been although infectious virus cannot be recovered past 10–
12 days after infection (Fleming et al., 1992, 1993). Posi-documented after oral infection with influenza virus in
ducks. Viral replication and clearance was confined to tive sense JHM RNA was more abundant after 13 days.
It was suggested that the later form may be of importancethe epithelial surfaces of the respiratory and intestinal
tracts (Wang and Webster, 1990). to pathogenesis since it is temporally associated with the
period of maximal demyelination, most intense antiviralTo understand the mechanism of VSV-NJ RNA persis-
tence, we attempted to identify the replicative intermedi- immune response, and the transition from productive to
persistent infection. Persistence of murine coronavirusate RNA in all the samples that contained genomic RNA.
This form was identified only in the spinal cord sample has also been associated with the loss of the hemaggluti-
nin-esterase protein (Yokomori et al., 1993). Similarly, thefrom hamster 9 that developed hind limb paralysis (Fig.
4). This does not imply that virus was still replicating in Sindbis virus positive sense RNA genome was detected
by RT-PCR in mouse brain at 8, 12, and 17 months afterthis anatomical site and due to the small amount of mate-
rial collected we could not attempt virus isolation. In infection (Levine and Griffin, 1992). The negative sense
RNA was not detected perhaps due to the low sensitivityhamster 9, L gene but not N gene genomic RNA was
detected (Fig. 3). This suggests the presence of incom- of the PCR reaction. Although Sindbis virus could be
isolated for only 7 days, B cells secreting antiviral anti-plete genomes and is consistent with the presence of
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changes in defective measles viruses in human brain infections. Cellbody predominated in brain tissues for a year (Tyor et
55, 255–265.al., 1992).
Cave, D. R., Hagen, F. S., Palma, E. L., and Huang, A. S. (1984). DetectionPersistence of viral RNA outside the central nervous of vesicular stomatitis virus RNA and its defective interfering particles
system may be common. Bluetongue viral RNA persists in individual mouse brains. J. Virol. 50, 86–91.
in bovine erythrocytes as long as 100 days following the Cave, D. R., Hendrickson, F. M., and Huang, A. S. (1985). Defective
interfering virus particles modulate virulence. J. Virol. 55, 366–373.disappearance of live virus (MacLachlan et al., 1994).
Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J., and Rutter, W. J. (1979).Human respiratory syncytial virus RNA but not recover-
Isolation of biologically active ribonucleic acid from sources enrichedable virus persists in guinea pig lungs at least 60 days
in ribonuclease. Biochemistry 18, 5294–5299.
following infection (Hegele et al., 1994). Coxsackievirus Chomczynski, P., and Sacchi, N. (1987). Single-step method of RNA
B1 RNA persisted in the muscles of mice at least 11 isolation by acid guanidinium thiocyanate-phenol-chloroform extrac-
tion. Analyt. Biochem. 162, 156–159.months following convalescence (Tam et al., 1994). In
Comer, J. A., Tesh, R. B., Modi, G. B., Corn, J. L., and Nettles, V. F.each of these cases, neither the length nor the activity
(1990). Vesicular stomatitis virus, New Jersey serotype: Replicationof the RNA was determined.
in and transmission by Lutzomyia shannoni (Diptera: Psychodidae).The consequences of viral RNA persistence in the Am. J. Trop. Med. Hyg. 42, 483–490.
brain include possible viral gene expression causing Corn, J. L., Comer, J. A., Erickson, G. A., and Nettles, V. F. (1990).
chronic cytopathology or immunopathology and the pos- Isolation of vesicular stomatitis virus New Jersey serotype from
phlebotomine sand flies in Georgia. Am. J. Trop. Med. Hyg. 42, 476–sibility of viral replication with eventual spread to other
482.hosts. At present we do not know the consequences of
DePolo, N. J., Giachetti, C., and Holland, J. J. (1987). Continuing coevolu-VSV-NJ RNA persistence.
tion of virus and defective interfering particles and of viral genome
sequences during undiluted passages: Virus mutants exhibiting
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